vs
安捷伦科技（A）与RXO, Inc.（RXO）财务数据对比。点击上方公司名可切换其他公司
安捷伦科技的季度营收约是RXO, Inc.的1.2倍（$1.8B vs $1.5B），安捷伦科技净利率更高（17.0% vs -3.1%，领先20.1%），安捷伦科技同比增速更快（7.0% vs -11.9%），安捷伦科技自由现金流更多（$175.0M vs $-9.0M），过去两年RXO, Inc.的营收复合增速更高（26.8% vs 6.9%）
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商，旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器，服务全球各领域客户。
RXO是总部位于美国的头部运输及物流解决方案供应商，核心业务覆盖货运经纪、大件商品最后一公里配送、运输管理服务与全链路供应链优化支持，主要服务北美制造业、零售业及电商领域的客户。
A vs RXO — 直观对比
营收规模更大
A
是对方的1.2倍
$1.5B
营收增速更快
A
高出18.8%
-11.9%
净利率更高
A
高出20.1%
-3.1%
自由现金流更多
A
多$184.0M
$-9.0M
两年增速更快
RXO
近两年复合增速
6.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $1.5B |
| 净利润 | $305.0M | $-46.0M |
| 毛利率 | 52.6% | — |
| 营业利润率 | 19.6% | -2.9% |
| 净利率 | 17.0% | -3.1% |
| 营收同比 | 7.0% | -11.9% |
| 净利润同比 | -4.1% | -84.0% |
| 每股收益（稀释后） | $1.07 | $-0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARXO
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $1.5B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.7B | $1.4B | ||
| Q1 25 | $1.7B | $1.4B | ||
| Q4 24 | $1.7B | $1.7B | ||
| Q3 24 | $1.6B | $1.0B | ||
| Q2 24 | $1.6B | $930.0M |
净利润ARXO
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $-46.0M | ||
| Q3 25 | $336.0M | $-14.0M | ||
| Q2 25 | $215.0M | $-9.0M | ||
| Q1 25 | $318.0M | $-31.0M | ||
| Q4 24 | $351.0M | $-25.0M | ||
| Q3 24 | $282.0M | $-243.0M | ||
| Q2 24 | $308.0M | $-7.0M |
毛利率ARXO
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | — | ||
| Q2 25 | 51.9% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
营业利润率ARXO
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | -2.9% | ||
| Q3 25 | 20.7% | -0.5% | ||
| Q2 25 | 18.0% | — | ||
| Q1 25 | 22.4% | -2.1% | ||
| Q4 24 | 24.0% | -1.4% | ||
| Q3 24 | 21.1% | -1.9% | ||
| Q2 24 | 23.1% | — |
净利率ARXO
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | -3.1% | ||
| Q3 25 | 19.3% | -1.0% | ||
| Q2 25 | 12.9% | -0.6% | ||
| Q1 25 | 18.9% | -2.2% | ||
| Q4 24 | 20.6% | -1.5% | ||
| Q3 24 | 17.9% | -23.4% | ||
| Q2 24 | 19.6% | -0.8% |
每股收益（稀释后）ARXO
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $-0.28 | ||
| Q3 25 | $1.18 | $-0.08 | ||
| Q2 25 | $0.75 | $-0.05 | ||
| Q1 25 | $1.11 | $-0.18 | ||
| Q4 24 | $1.23 | $-0.17 | ||
| Q3 24 | $0.97 | $-1.81 | ||
| Q2 24 | $1.05 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | $17.0M |
| 总债务越低越好 | $3.0B | $387.0M |
| 股东权益账面价值 | $6.9B | $1.5B |
| 总资产 | $12.8B | $3.3B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资ARXO
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $17.0M | ||
| Q3 25 | $1.5B | $25.0M | ||
| Q2 25 | $1.5B | $18.0M | ||
| Q1 25 | $1.5B | $16.0M | ||
| Q4 24 | $1.3B | $35.0M | ||
| Q3 24 | $1.8B | $55.0M | ||
| Q2 24 | $1.7B | $7.0M |
总债务ARXO
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $387.0M | ||
| Q3 25 | $3.4B | $387.0M | ||
| Q2 25 | $3.3B | $387.0M | ||
| Q1 25 | $3.3B | $387.0M | ||
| Q4 24 | $3.3B | $351.0M | ||
| Q3 24 | $2.1B | $352.0M | ||
| Q2 24 | $2.1B | $370.0M |
股东权益ARXO
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $1.5B | ||
| Q3 25 | $6.4B | $1.6B | ||
| Q2 25 | $6.1B | $1.6B | ||
| Q1 25 | $6.0B | $1.6B | ||
| Q4 24 | $5.9B | $1.6B | ||
| Q3 24 | $5.9B | $1.7B | ||
| Q2 24 | $6.2B | $579.0M |
总资产ARXO
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $3.3B | ||
| Q3 25 | $12.2B | $3.2B | ||
| Q2 25 | $12.2B | $3.2B | ||
| Q1 25 | $11.9B | $3.3B | ||
| Q4 24 | $11.8B | $3.4B | ||
| Q3 24 | $11.0B | $3.4B | ||
| Q2 24 | $10.9B | $1.8B |
负债/权益比ARXO
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | 0.25× | ||
| Q3 25 | 0.53× | 0.24× | ||
| Q2 25 | 0.55× | 0.24× | ||
| Q1 25 | 0.56× | 0.24× | ||
| Q4 24 | 0.57× | 0.22× | ||
| Q3 24 | 0.36× | 0.21× | ||
| Q2 24 | 0.34× | 0.64× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $268.0M | $7.0M |
| 自由现金流经营现金流 - 资本支出 | $175.0M | $-9.0M |
| 自由现金流率自由现金流/营收 | 9.7% | -0.6% |
| 资本支出强度资本支出/营收 | 5.2% | 1.1% |
| 现金转化率经营现金流/净利润 | 0.88× | — |
| 过去12个月自由现金流最近4个季度 | $993.0M | $-8.0M |
8季度趋势，按日历期对齐
经营现金流ARXO
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $7.0M | ||
| Q3 25 | $362.0M | $23.0M | ||
| Q2 25 | $221.0M | $23.0M | ||
| Q1 25 | $431.0M | $-2.0M | ||
| Q4 24 | $481.0M | $-7.0M | ||
| Q3 24 | $452.0M | $-7.0M | ||
| Q2 24 | $333.0M | $-5.0M |
自由现金流ARXO
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $-9.0M | ||
| Q3 25 | $259.0M | $9.0M | ||
| Q2 25 | $107.0M | $9.0M | ||
| Q1 25 | $334.0M | $-17.0M | ||
| Q4 24 | $388.0M | $-19.0M | ||
| Q3 24 | $360.0M | $-18.0M | ||
| Q2 24 | $230.0M | $-16.0M |
自由现金流率ARXO
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | -0.6% | ||
| Q3 25 | 14.9% | 0.6% | ||
| Q2 25 | 6.4% | 0.6% | ||
| Q1 25 | 19.9% | -1.2% | ||
| Q4 24 | 22.8% | -1.1% | ||
| Q3 24 | 22.8% | -1.7% | ||
| Q2 24 | 14.6% | -1.7% |
资本支出强度ARXO
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 1.1% | ||
| Q3 25 | 5.9% | 1.0% | ||
| Q2 25 | 6.8% | 1.0% | ||
| Q1 25 | 5.8% | 1.0% | ||
| Q4 24 | 5.5% | 0.7% | ||
| Q3 24 | 5.8% | 1.1% | ||
| Q2 24 | 6.5% | 1.2% |
现金转化率ARXO
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | — | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.08× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
